Eduardo Ansorena

4.7k total citations · 1 hit paper
30 papers, 3.7k citations indexed

About

Eduardo Ansorena is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Immunology. According to data from OpenAlex, Eduardo Ansorena has authored 30 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 9 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Eduardo Ansorena's work include Nerve injury and regeneration (10 papers), Nitric Oxide and Endothelin Effects (5 papers) and Liver physiology and pathology (5 papers). Eduardo Ansorena is often cited by papers focused on Nerve injury and regeneration (10 papers), Nitric Oxide and Endothelin Effects (5 papers) and Liver physiology and pathology (5 papers). Eduardo Ansorena collaborates with scholars based in Spain, Belgium and United Kingdom. Eduardo Ansorena's co-authors include Véronique Préat, Fabienne Danhier, Régis Coco, Joana M. Silva, Aude Le Breton, María J. Blanco‐Prieto, Elisa Garbayo, José L. Lanciego, María J. Iraburu and Marta Aymerich and has published in prestigious journals such as Biomaterials, Hepatology and Free Radical Biology and Medicine.

In The Last Decade

Eduardo Ansorena

30 papers receiving 3.7k citations

Hit Papers

PLGA-based nanoparticles: An overview of biomedical appli... 2012 2026 2016 2021 2012 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. PLGA-based nanoparticles: An overview of biomedical applications
    2012 2.8k citations Fabienne Danhier, Eduardo Ansorena et al. Journal of Controlled Release profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eduardo Ansorena Spain 17 1.4k 1.1k 987 854 369 30 3.7k
Anne des Rieux Belgium 40 1.8k 1.3× 1.8k 1.6× 1000 1.0× 2.0k 2.3× 557 1.5× 88 5.9k
Régis Coco Belgium 9 1.5k 1.1× 983 0.9× 941 1.0× 1.1k 1.3× 349 0.9× 9 3.7k
María J. Blanco‐Prieto Spain 45 1.8k 1.3× 1.8k 1.6× 1.4k 1.4× 1.2k 1.4× 223 0.6× 146 5.7k
Aude Le Breton Belgium 3 1.6k 1.1× 1.4k 1.3× 1.2k 1.2× 792 0.9× 365 1.0× 3 3.8k
Zimei Wu New Zealand 40 2.0k 1.4× 2.3k 2.1× 1.8k 1.8× 964 1.1× 320 0.9× 179 5.8k
Hu Yang United States 41 1.5k 1.1× 1.8k 1.7× 1.2k 1.2× 575 0.7× 292 0.8× 135 4.8k
Sarah Hedtrich Germany 37 695 0.5× 912 0.8× 657 0.7× 1.2k 1.4× 242 0.7× 101 3.7k
Uday B. Kompella United States 54 1.1k 0.8× 2.8k 2.5× 1.2k 1.2× 2.0k 2.3× 231 0.6× 195 8.0k
Jinning Lou China 37 1.4k 1.0× 2.2k 2.0× 734 0.7× 343 0.4× 425 1.2× 76 4.4k
Ying‐Zheng Zhao China 46 1.9k 1.3× 1.7k 1.6× 1.8k 1.8× 630 0.7× 377 1.0× 163 6.1k

Countries citing papers authored by Eduardo Ansorena

Since Specialization
Citations

This map shows the geographic impact of Eduardo Ansorena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo Ansorena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo Ansorena more than expected).

Fields of papers citing papers by Eduardo Ansorena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduardo Ansorena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo Ansorena. The network helps show where Eduardo Ansorena may publish in the future.

Co-authorship network of co-authors of Eduardo Ansorena

This figure shows the co-authorship network connecting the top 25 collaborators of Eduardo Ansorena. A scholar is included among the top collaborators of Eduardo Ansorena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduardo Ansorena. Eduardo Ansorena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pejenaute, Álvaro, Eduardo Ansorena, Gloria Abizanda, et al.. (2023). Endothelial NOX5 overexpression induces changes in the cardiac gene profile: potential impact in myocardial infarction?. Journal of Physiology and Biochemistry. 79(4). 787–797. 1 indexed citations
2.
Galarreta, Marina Ruiz de, et al.. (2022). Antifibrogenic and apoptotic effects of Ocoxin in cultured rat hepatic stellate cells. Journal of Physiology and Biochemistry. 79(4). 881–890. 2 indexed citations
3.
Smerdou, Cristian, et al.. (2021). Optimization of a GDNF production method based on Semliki Forest virus vector. European Journal of Pharmaceutical Sciences. 159. 105726–105726. 3 indexed citations
4.
López‐Zabalza, María J., Juan J. Martínez‐Irujo, Gloria Álvarez‐Sola, et al.. (2019). Role of AGAP2 in the profibrogenic effects induced by TGFβ in LX-2 hepatic stellate cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1866(4). 673–685. 15 indexed citations
5.
Garbayo, Elisa, Eduardo Ansorena, Hugo Lana, et al.. (2016). Brain delivery of microencapsulated GDNF induces functional and structural recovery in parkinsonian monkeys. Biomaterials. 110. 11–23. 53 indexed citations
6.
Galarreta, Marina Ruiz de, et al.. (2016). Unfolded protein response induced by Brefeldin A increases collagen type I levels in hepatic stellate cells through an IRE1α, p38 MAPK and Smad-dependent pathway. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1863(8). 2115–2123. 38 indexed citations
7.
Andueza, Aitor, Marina Ruiz de Galarreta, Eduardo Ansorena, et al.. (2015). Oxidation pathways underlying the pro-oxidant effects of apigenin. Free Radical Biology and Medicine. 87. 169–180. 24 indexed citations
8.
Garbayo, Elisa, Eduardo Ansorena, & María J. Blanco‐Prieto. (2013). Drug development in Parkinson's disease: From emerging molecules to innovative drug delivery systems. Maturitas. 76(3). 272–278. 70 indexed citations
9.
Ansorena, Eduardo, Pauline De Berdt, Bernard Učakar, et al.. (2013). Injectable alginate hydrogel loaded with GDNF promotes functional recovery in a hemisection model of spinal cord injury. International Journal of Pharmaceutics. 455(1-2). 148–158. 85 indexed citations
10.
Danhier, Fabienne, Eduardo Ansorena, Joana M. Silva, et al.. (2012). PLGA-based nanoparticles: An overview of biomedical applications. Journal of Controlled Release. 161(2). 505–522. 2832 indexed citations breakdown →
11.
Ansorena, Eduardo, Erkuden Casales, Esther Tamayo, et al.. (2012). A simple and efficient method for the production of human glycosylated glial cell line-derived neurotrophic factor using a Semliki Forest virus expression system. International Journal of Pharmaceutics. 440(1). 19–26. 10 indexed citations
12.
Garbayo, Elisa, Eduardo Ansorena, & María J. Blanco‐Prieto. (2012). Brain Drug Delivery Systems for Neurodegenerative Disorders. Current Pharmaceutical Biotechnology. 13(12). 2388–2402. 12 indexed citations
13.
Ansorena, Eduardo, Elisa Garbayo, José L. Lanciego, Marta Aymerich, & María J. Blanco‐Prieto. (2009). Production of highly pure human glycosylated GDNF in a mammalian cell line. International Journal of Pharmaceutics. 385(1-2). 6–11. 9 indexed citations
14.
Garbayo, Elisa, Claudia N. Montero‐Menei, Eduardo Ansorena, et al.. (2008). Effective GDNF brain delivery using microspheres—A promising strategy for Parkinson's disease. Journal of Controlled Release. 135(2). 119–126. 115 indexed citations
15.
Garbayo, Elisa, Eduardo Ansorena, José L. Lanciego, Marta Aymerich, & María J. Blanco‐Prieto. (2008). Sustained release of bioactive glycosylated glial cell-line derived neurotrophic factor from biodegradable polymeric microspheres. European Journal of Pharmaceutics and Biopharmaceutics. 69(3). 844–851. 46 indexed citations
16.
Garbayo, Elisa, Eduardo Ansorena, José L. Lanciego, Marta Aymerich, & María J. Blanco‐Prieto. (2007). Purification of bioactive glycosylated recombinant glial cell line-derived neurotrophic factor. International Journal of Pharmaceutics. 344(1-2). 9–15. 18 indexed citations
17.
Ansorena, Eduardo, et al.. (2006). Differential regulation of the JNK/AP-1 pathway byS-adenosylmethionine and methylthioadenosine in primary rat hepatocytes versus HuH7 hepatoma cells. American Journal of Physiology-Gastrointestinal and Liver Physiology. 290(6). G1186–G1193. 10 indexed citations
18.
Garbayo, Elisa, Marta Aymerich, Eduardo Ansorena, José L. Lanciego, & María J. Blanco‐Prieto. (2006). Terapias neuroprotectoras y neurorestauradoras en el tratamiento de la enfermedad de Parkinson. Anales del Sistema Sanitario de Navarra. 29(3). 325–35. 1 indexed citations
19.
Montiel‐Duarte, Cristina, Eduardo Ansorena, María J. López‐Zabalza, Edurne Cenarruzabeitia, & María J. Iraburu. (2003). Role of reactive oxygen species, glutathione and NF-κB in apoptosis induced by 3,4-methylenedioxymethamphetamine (“Ecstasy”) on hepatic stellate cells. Biochemical Pharmacology. 67(6). 1025–1033. 59 indexed citations
20.
Ansorena, Eduardo, Elena R. García–Trevijano, Maria Luz Martínez‐Chantar, et al.. (2002). S-adenosylmethionine and methylthioadenosine are antiapoptotic in cultured rat hepatocytes but proapoptotic in human hepatoma cells. Hepatology. 35(2). 274–280. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne des Rieux Breakdown of academic impact, for papers by Régis Coco Breakdown of academic impact, for papers by María J. Blanco‐Prieto Breakdown of academic impact, for papers by Aude Le Breton Breakdown of academic impact, for papers by Zimei Wu Breakdown of academic impact, for papers by Hu Yang Breakdown of academic impact, for papers by Sarah Hedtrich Breakdown of academic impact, for papers by Uday B. Kompella Breakdown of academic impact, for papers by Jinning Lou Breakdown of academic impact, for papers by Ying‐Zheng Zhao
Rankless by CCL
2026